MedPath

A clinical trial to assess the efficacy of using the drug gabapentin as premedication on mean blood pressure and heart rate in patients undergoing laparoscopic cholecystectomy

Phase 4
Completed
Registration Number
CTRI/2010/091/001445
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

ASA grade I and II patients, aged 18-65 years, undergoing elective laparoscopic cholecystectomy

Exclusion Criteria

Hypertension, morbid obesity and severe hepatic, renal, endocrine and cardiac dysfunction, dizziness or frequent headaches, currently taking sedatives or anticonvulsants.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean arterial pressure and heart rate in both groups of patientsTimepoint: 15 minutes interval throughout surgery
Secondary Outcome Measures
NameTimeMethod
parameters of recoveryTimepoint: time to tracheal extubation; time to respond to verbal command; orientation time
© Copyright 2025. All Rights Reserved by MedPath